Spectroscopy analysis of uterine leiomyomas before and after treatment with GnRH-a
dc.contributor.author | Hasçalık, Şeyma | |
dc.contributor.author | Çelik, Önder | |
dc.contributor.author | Saraç, Kaya | |
dc.contributor.author | Alkan, Alpay | |
dc.contributor.author | Mızrak, Bülent | |
dc.date.accessioned | 2020-06-02T10:37:18Z | |
dc.date.available | 2020-06-02T10:37:18Z | |
dc.date.issued | 2005 | |
dc.department | İnönü Üniversitesi | en_US |
dc.description | Öz: Başlık (İngilizce): Öz (İngilizce):MR spectroscopy uses the same hardware as magnetic resonance imaging but provides information at the biochemical level. It has been used to measure proton-containing compounds, such as amino acids, fatty acids, organic acids, sugars and other metabolic active compounds in tissue specimens. Before and after GnRH-a treatment we measured lipid, lactate, creatine and choline concentrations in two patients with uterine leiomyomas using single-voxel proton MR spectroscopy. Subcutaneous goserelin acetate injection was performed at least two times every 4 weeks before surgery. Spectroscopy was performed 3 weeks later last goserelin acetate injection. The MR spectroscopy results of leiomyomas before and after GnRH-a treatment were compared. Before GnRH-a treatment, spectral analysis of each patients showed only choline signals. After GnRH-a treatment, spectrum of both patients showed lipid peaks but the other signals were not observed. The presence of lipid signals and absence of other signals suggest a diffuse metabolic defect in association with GnRHa treatment, possibly consistent with decrease in myoflaments, and increase in apopitosis and necrosis. | en_US |
dc.description.abstract | Öz: Başlık (İngilizce): Öz (İngilizce): MR spectroscopy uses the same hardware as magnetic resonance imaging but provides information at the biochemical level. It has been used to measure proton-containing compounds, such as amino acids, fatty acids, organic acids, sugars and other metabolic active compounds in tissue specimens. Before and after GnRH-a treatment we measured lipid, lactate, creatine and choline concentrations in two patients with uterine leiomyomas using single-voxel proton MR spectroscopy. Subcutaneous goserelin acetate injection was performed at least two times every 4 weeks before surgery. Spectroscopy was performed 3 weeks later last goserelin acetate injection. The MR spectroscopy results of leiomyomas before and after GnRH-a treatment were compared. Before GnRH-a treatment, spectral analysis of each patients showed only choline signals. After GnRH-a treatment, spectrum of both patients showed lipid peaks but the other signals were not observed. The presence of lipid signals and absence of other signals suggest a diffuse metabolic defect in association with GnRHa treatment, possibly consistent with decrease in myoflaments, and increase in apopitosis and necrosis. | en_US |
dc.identifier.citation | Şeyma H., Önder Ç., Kaya S., Alpay A., Bülent M. (2005). Spectroscopy analysis of uterine leiomyomas before and after treatment with GnRH-a, GORM:Gynecology Obstetrics & Reproductive Medicine, GORM:Gynecology Obstetrics & Reproductive Medicine | en_US |
dc.identifier.endpage | 144 | en_US |
dc.identifier.issn | 1300-4751 | |
dc.identifier.issn | 2602-4918 | |
dc.identifier.issue | 2 | en_US |
dc.identifier.startpage | 141 | en_US |
dc.identifier.trdizinid | 58688 | en_US |
dc.identifier.uri | https://hdl.handle.net/11616/15644 | |
dc.identifier.uri | https://search.trdizin.gov.tr/yayin/detay/58688 | |
dc.identifier.volume | 11 | en_US |
dc.indekslendigikaynak | TR-Dizin | en_US |
dc.language.iso | tr | en_US |
dc.publisher | GORM:Gynecology Obstetrics & Reproductive Medicine | en_US |
dc.relation.ispartof | GORM:Gynecology Obstetrics & Reproductive Medicine | en_US |
dc.relation.publicationcategory | Makale - Ulusal Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | Kadın Hastalıkları ve Doğum | en_US |
dc.title | Spectroscopy analysis of uterine leiomyomas before and after treatment with GnRH-a | en_US |
dc.type | Article | en_US |